LIGAND PHARMACEUTICALS INCORPORATED Stock Repurchased During Period, Shares
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, shares for the quarter ending 2014-12-31 was 560.63K shares.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, shares for the quarter ending 2014-09-30 was 692.80K shares.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, shares for fiscal 2020 was 934.08K shares, a 77.34% decline from fiscal 2019.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, shares for fiscal 2019 was 4.12M shares, a 426.96% increase from fiscal 2018.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, shares for fiscal 2018 was 782.25K shares, a 5487.49% increase from fiscal 2017.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, shares for fiscal 2017 was 14.00K shares, a 65.43% decline from fiscal 2016.
| Period end | Stock Repurchased During Period, Shares 3 month | Stock Repurchased During Period, Shares 12 month |
|---|---|---|
| 2020-12-31 | 934.08K shares 10-K · filed 2023-02-28 | |
| 2019-12-31 | 4.12M shares 10-K · filed 2022-02-28 | |
| 2018-12-31 | 782.25K shares 10-K · filed 2021-02-24 | |
| 2017-12-31 | 14.00K shares 10-K · filed 2020-02-27 | |
| 2016-12-31 | 40.50K shares 10-K · filed 2019-02-28 | |
| 2015-12-31 | 6.12K shares 10-K · filed 2018-03-01 | |
| 2014-12-31 | 560.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 1.25M shares 10-K · filed 2017-02-28 |
| 2014-09-30 | 692.80K shares 10-Q · filed 2014-10-31 |